Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

A meta-analysis of cytokines in Alzheimer's disease.

Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N.

Biol Psychiatry. 2010 Nov 15;68(10):930-41. doi: 10.1016/j.biopsych.2010.06.012. Epub 2010 Aug 8.

PMID:
20692646
2.

Peripheral cytokines and chemokines in Alzheimer's disease.

Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, Hong CH.

Dement Geriatr Cogn Disord. 2009;28(4):281-7. doi: 10.1159/000245156. Epub 2009 Oct 10. Review.

3.

Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.

Ventriglia M, Bucossi S, Panetta V, Squitti R.

J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244. Review.

PMID:
22475798
4.

Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.

Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jönhagen M.

Dement Geriatr Cogn Disord. 2009;27(5):481-90. doi: 10.1159/000218081. Epub 2009 May 12.

PMID:
19439966
5.

Some remarks on biological markers of Alzheimer's disease.

Robles A.

Neurobiol Aging. 1998 Mar-Apr;19(2):153-7. Review. No abstract available.

PMID:
9558153
6.

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.

Pirttila T, Mehta PD, Frey H, Wisniewski HM.

Neurobiol Aging. 1994 May-Jun;15(3):313-7.

PMID:
7936055
7.

Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.

Malekzadeh A, de Groot V, Beckerman H, van Oosten BW, Blankenstein MA, Teunissen C.

Methods. 2012 Apr;56(4):508-13. doi: 10.1016/j.ymeth.2012.03.017. Epub 2012 Mar 24. Review.

PMID:
22465283
8.

Biomarkers of mild cognitive impairment and Alzheimer's disease.

Tang BL, Kumar R.

Ann Acad Med Singapore. 2008 May;37(5):406-10.

9.

Amyloid beta protein in plasma as a diagnostic marker for Alzheimer's disease.

Iwatsubo T.

Neurobiol Aging. 1998 Mar-Apr;19(2):161-3. No abstract available.

PMID:
9558155
10.

Biomarkers of Alzheimer's disease in body fluids.

Zheng Y, He J, Hong T.

Sci China Life Sci. 2010 Apr;53(4):490-6. doi: 10.1007/s11427-010-0081-9. Epub 2010 May 7. Review.

PMID:
20596916
11.

Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease.

Duplan L, Michel B, Boucraut J, Barthellémy S, Desplat-Jego S, Marin V, Gambarelli D, Bernard D, Berthézène P, Alescio-Lautier B, Verdier JM.

Neurobiol Aging. 2001 Jan-Feb;22(1):79-88.

PMID:
11164279
12.

Biological markers of Alzheimer's disease and mild cognitive impairment.

Maccioni RB, Lavados M, Maccioni CB, Mendoza-Naranjo A.

Curr Alzheimer Res. 2004 Nov;1(4):307-14. Review.

PMID:
15975059
13.

Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89. Review.

14.

Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease.

Paraskevas GP, Kapaki E, Libitaki G, Zournas C, Segditsa I, Papageorgiou C.

Acta Neurol Scand. 1997 Aug;96(2):88-90.

PMID:
9272183
15.

Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.

Lee KS, Chung JH, Lee KH, Shin MJ, Oh BH, Hong CH.

Immunol Lett. 2008 Dec 22;121(2):105-9. doi: 10.1016/j.imlet.2008.09.004. Epub 2008 Oct 18. Erratum in: Immunol Lett. 2009 Mar 24;123(1):96.

PMID:
18930766
16.

Diagnostic biomarker for early stage of Alzheimer's disease: current state and view in the future.

Urakami K.

Psychogeriatrics. 2010 Jun;10(2):49-52. doi: 10.1111/j.1479-8301.2010.00331.x. No abstract available.

17.

Interleukins, inflammation, and mechanisms of Alzheimer's disease.

Weisman D, Hakimian E, Ho GJ.

Vitam Horm. 2006;74:505-30. Review.

PMID:
17027528
18.

Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment.

Guerreiro RJ, Santana I, Brás JM, Santiago B, Paiva A, Oliveira C.

Neurodegener Dis. 2007;4(6):406-12. Epub 2007 Oct 9.

PMID:
17934323
19.

Biological markers and the treatment of Alzheimer's disease.

Galasko D.

J Mol Neurosci. 2001 Oct;17(2):119-25. Review.

PMID:
11816785
20.

Inflammatory markers in Alzheimer's disease and multi-infarct dementia.

De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M.

Mech Ageing Dev. 2001 Nov;122(16):1985-95.

PMID:
11589916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk